Related news:
AbbVie shares tumble after schizophrenia drug disappoints - Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more - Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up - AbbVie is buying an Alzheimer's drug for more than $1 billion - AbbVie's newer drugs are offsetting losses of the world's once best-selling medication - Copycats take bite out of AbbVie's best-selling Humira drug - $19 Billion in a Week: AbbVie Makes Two Big Bets - AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion - AbbVie to Buy Cerevel Therapeutics for $8.7 Billion
Summary
Abbvie.De is a company. It is located in Germany. The company is part of the Health Care sector.
Business
Abbvie.De is one of the 3,466,499 companies in our database.
Companies from Germany
Companies in the Health Care sector
Stocks from Abbvie.De
Explore more on business
Talking Points:
- AbbVie | BioPharma-Forschung, die einen Unterschied macht
- AbbVie ist ein globales, forschendes Bio-Pharma-Unternehmen. Wir leisten einen entscheidenden Beitrag für die Gesundheitsversorgung von Patienten.
- Willkommen beim forschenden BioPharma-Unternehmen AbbVie Deutschland! Es twittert die Unternehmenskommunikation. Twitter-Guideline: https://t.co/YJ3lOqYGbq
- We use advanced science, expertise & passion to solve serious health issues & have a remarkable impact on people's lives | AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key ...
Learn more about talking points
